Scientists have not given up on the drugs for these conditions, but they will need to pivot, focusing on new GLP-1 research questions spurred by the trials results
Since exenatide is the only available GLP-1 receptor agonist covered by insurance in Turkey, a drug desensitization protocol, the only therapeutic method in hypersensitivity reactions used in case of absence of an alternative drug, was considered
These enhancements were speculated to be a direct effect of liraglutide, rather than an effect of decreased blood glucose, which was achieved by dapagliflozin and acarbose [91]
Some individuals notice their hair never quite reaches the same density as pre-medication, though this is relatively rare with pure telogen effluvium
Safety considerations include baseline renal function, cardiovascular history, pancreatitis risk, and medication interactions
Whalley, N